A Thromboelastography Market, By Type (Standard (kaolin), Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen, Platelet Mapping), By Application (Cardiopulmonary Bypass, Liver Surgery, Trauma surgery, Obstetrics), By End User (Hospitals, Blood Banks

Thromboelastography Market, By Type (Standard (kaolin), Rapid TEG, Native TEG, Heparinase, Functional Fibrinogen, Platelet Mapping), By Application (Cardiopulmonary Bypass, Liver Surgery, Trauma surgery, Obstetrics), By End User (Hospitals, Blood Banks, Academic Institutes, Others (Research Laboratories, Research Institutes)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

The thromboelastography protects against the severe blood loss or hemorrhage occurred during severe injury or during a surgery. Thromboelastography (TEG) is more frequently used in cardiac surgery, organ transplants, and arteriovenous malformation surgeries where the anticipated blood loss is greater than 40% of the circulating blood volume because it performs an in vitro analysis of the relationship between platelets, enzymes, fibrinogen, and other coagulation elements in a comprehensive manner. Through platelet mapping, patients using antiaggregants like clopidogrel or aspirin can have their platelet activity assessed. This is made possible by include TEG in the pre-anesthetic assessment.

Market Dynamics

Increasing initiatives in developing new methods by market players is expected to boost the growth of global thromboelastography market over the forecast period. For instance, on February 20, 2022, an article published in national library of medicine, asserted that Coagulopathies pose additional diagnostic and therapeutic difficulties in the field of otolaryngology—head and neck surgery (ENT). Management of coagulopathies in both hyper- and hypocoagulable individuals necessitates careful consideration of the nature of hemostatic competence. Viscoelastic tests (VETs) such as thromboelastography (TEG) and rotational thromboelastometry (ROTEM) have long been methods of guiding blood component therapy (BCT). VETs have been widely adopted for the diagnosis and management of trauma-induced coagulopathy and bleeding conditions.

Increasing in the rate of new approvals by regulatory authorities such as the U.S. FDA is likely to boost the growth of global thromboelastography market over the forecast period. For instance, on January 11, 2021, Abbott Laboratories is a multinational company engaged in manufacturing and research of medical devices and health care products. Abbott received an FDA 510(k) clearance for the first rapid handheld blood test for concussion. The i-STAT Alinity handheld device from Abbott will be used to provide the test to help diagnose mild traumatic brain injury (TBI), also known as concussion. The test results are available 15 minutes after inserting a plasma sample.

Key features of the study: This report provides an in-depth analysis of the global thromboelastography market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players It profiles key players in the global thromboelastography market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies Key companies covered as a part of this study include Lepu Medical Technology (Beijing) Co.,Ltd., Render Biotech Co., Haemonetics Corporation, TA Instruments, HemaCore LLC, 5-Diagnostics, Xenometrix AG, Framar Hemologix srl, Instrumentation Laboratory, Medirox AB, Diagnostica Stago, Life Diagnostica, SYCOmed e.K., Nordic Biomarker, and Shenzhen Ultra-Diagnostics Biotec. Co., Ltd. Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics The global thromboelastography market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global thromboelastography marketDetailed Segmentation: Global Thromboelastography Market, by Type:Standard (kaolin)Rapid TEGNative TEGHeparinaseFunctional FibrinogenPlatelet Mapping Global Thromboelastography Market, by Application :Cardiopulmonary BypassLiver SurgeryTrauma surgeryObstetrics Global Thromboelastography Market, by End User :HospitalsBlood BanksAcademic InstitutesOthers (Research Laboratories, Research Institutes) Global Thromboelastography Market, By Region:North AmericaBy Country:U.S.CanadaLatin AmericaBy Country:BrazilMexicoArgentinaRest of Latin AmericaEuropeBy Country:U.K.GermanyItalySpainFranceRussiaRest of EuropeAsia PacificBy Country:AustraliaIndiaChinaJapanASEANSouth KoreaRest of Asia PacificMiddle EastBy Country:GCCIsraelRest of Middle EastAfricaBy Country/Region:South AfricaCentral AfricaNorth Africa Company ProfilesLepu Medical Technology (Beijing) Co.,Ltd *Company HighlightsProducts PortfolioKey HighlightsFinancial PerformanceStrategiesRender Biotech Co.Haemonetics CorporationTA InstrumentsHemaCore LLC5-DiagnosticsXenometrix AGFramar Hemologix srlInstrumentation LaboratoryMedirox ABDiagnostica StagoLife DiagnosticaSYCOmed e.K.Nordic BiomarkerShenzhen Ultra-Diagnostics Biotec. Co., Ltd.“*” marked represents similar segmentation in other categories in the respective section.